Sorrento Therapeutics Completes Enrollment of Phase 2 Clinical Trial of Resiniferatoxin ...

Given the durability of OAK pain relief response to RTX demonstrated in earlier phase 1/2 trials, Sorrento has decided to include an active comparator ...
READ MORE